The head of a Russian state-owned investment fund, Kirill Dmitriev, said on Nov. 24 that Russia would sell the Sputnik V nasal vaccine to other countries next year, according to televised footage obtained by Reuters.
The Russian Direct Investment Fund (RDIF), responsible for marketing Russia’s domestically produced vaccine overseas, made the announcement after President Vladimir Putin took the Sputnik booster shot last week.
Putin received his first dose of Sputnik V in April this year and was boosted with Sputnik Light last week.
He described being asked to breathe in, then being administered the vaccine through a syringe, in a statement to state-run media TASS.
The president also told TASS that he felt well after the booster. “I was revaccinated two hours ago. I feel nothing. I am in normal condition. Everything is all right,” he said.
“Exactly six months after vaccination my titers of protective [antibodies] have dropped, and specialists recommended the procedure of revaccination, which I did,” Putin added, according to The Hill.
Of the 16,427 in the vaccine group, 45 reported serious adverse effects while three died, however the Lancet concluded that “none of [the deaths] were considered related to the vaccine.”
In the face of rising COVID-19 cases in October, Putin addressed vaccine hesitancy by warning against “illness and its grave consequences.”
“I can’t understand what’s going on,” Putin said. “We have a reliable and efficient vaccine. The vaccine really reduces the risks of illness, grave complications, and death.”
According to RDIF, the Russian Health Ministry plans on registering the Sputnik V vaccine for adolescents between 12 and 17 years of age.